What's new?

[Guest guest]

Greetings,

Links to items below are provided in What's New:

www.lymphomation.org/current.htm

* orbital MALT:

Treatment with the Zevalin® Therapeutic Regimen as Sole Therapy Produces 83

Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT)

Orbital Lymphoma http://news.prnewswire.com

n = 9 patients with MALT lymphoma of conjunctiva or orbit and 3 patients with

low grade follicular lymphoma

* Review:

Radio-Immunotherapy with Zevalin®: Updates from the 2006 American Society of

Hematology Meeting http://professional.cancerconsultants.com

Review:

CLL diagnosis and prognosis: implications of the IWCLL guidelines

Owen, Haematological Malignancy Diagnostic Service (HMDS) 2009

" It is important to recognize that the value of the cellular prognostic markers

detailed is very much determined by the clinical context in which they are

demonstrated. "

* Commentary on Homeopathy: The side effects of inert " remedies " PDF

* Biospecimen-based study:

Impact of the tumor microenvironment on prognosis in follicular lymphoma is

dependent on specific treatment protocols

n = Pre-treatment biopsy samples of 61 pts with follicular lymphoma treated in

an EORTC/BNLI study

* Editorial:

Clinicobiological, prognostic and therapeutic implications of the tumor

microenvironment in follicular lymphoma

* On science-based medicine:

Natural versus " natural " in CAMworld

* Recruiting:

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic

Cancer

* Preclinical:

Grape Seed Extract Kills Laboratory Leukemia Cells, Proving? Value of Natural

Compounds

* CLL

Flavopiridol Confirmed Active for Treatment of Relapsed CLL with Adverse

Cytogenetics

n = 62 patients with relapsed CLL treated with flavopiridol... pretreated with

dexamethasone to block the effects of IL-6 release during therapy.

~ Karl

Patients Against Lymphoma

Non-profit | Independent | Evidence-based

How to Help: www.lymphomation.org/how-to-help.htm